Compare Medpace Holdings Inc (MEDP) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs United States Natural Gas Fund — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while United States Natural Gas Fund trades at $11.01 (market cap $517.27M). The key difference: Medpace Holdings Inc is far larger — about 32.5× United States Natural Gas Fund's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and United States Natural Gas Fund for 22 Days on average.
| MEDP | UNG | |
|---|---|---|
Market Cap | $16.82B | $517.27M |
Volume | 223,093 | 29,485,537 |
Sector | Health | Commodities - Energy |
52-Week High | $630.19 | $16.90 |
52-Week Low | $393.42 | $9.63 |
Typical Hold Time | 14 Days | 22 Days |
Enterprise Value | $16.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
UNG trades at $11.01, down 0.18% on the day, with a bullish technical signal from moving averages and neutral oscillators. The fund reported a net income of $65.15 million for 2024, though revenue was $0, and maintains a strong balance sheet with total assets of $790.02 million and minimal liabilities. Recent news highlights record U.S. natural gas production and geopolitical tensions affecting energy markets.
The outlook for UNG is mixed, with bullish technicals and solid financials offset by exposure to volatile natural gas prices and high production levels. Investment opportunities lie in potential geopolitical supply disruptions, while risks include weather-dependent demand and sustained high output pressuring prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
